Skip to content

Clinical trials

Breast Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Diseases Country / region: France Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20151
20191
20213
20223
20231
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting4
Recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Assistance Publique - Hôpitaux de Paris1
Atavistik Bio, Inc1
Eli Lilly and Company1
Fondation Hôpital Saint-Joseph1
Hoffmann-La Roche1
Institut Cancerologie de l'Ouest1
Novartis Pharmaceuticals1
Stemline Therapeutics, Inc.1
University Hospital, Strasbourg, France1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Diseases13
Breast Neoplasms11
Neoplasms8
Neoplasms by Site8
Neoplasm Metastasis4
Endometrial Neoplasms2
Ovarian Neoplasms2
Skin Diseases2
Triple Negative Breast Neoplasms2
Uterine Cervical Neoplasms2

Trials

Showing 76 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.